Email Alert RSS
Volume 10 Issue 2
Sep.  2020
Turn off MathJax
Article Contents
Abstract
References
Related Articles
Lin-xia WANG, Na SU, Ning-ning GUO, Guo-xin BAI, Yun-na ZHANG, Xiao-peng ZHAO, Gui-mei JI, Fang GAO, Guang-ya WANG, Jin-xiu XU, Rui-xin GAO. Correlation of 25-hydroxy Vitamin D and Lipoprotein-associated Phospholipase A2 with Diabetic Retinopathy: A Single-center Retrospective Study[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(2): 143-147. DOI: 10.3969/j.issn.1674-9081.2019.02.011
Citation: Lin-xia WANG, Na SU, Ning-ning GUO, Guo-xin BAI, Yun-na ZHANG, Xiao-peng ZHAO, Gui-mei JI, Fang GAO, Guang-ya WANG, Jin-xiu XU, Rui-xin GAO. Correlation of 25-hydroxy Vitamin D and Lipoprotein-associated Phospholipase A2 with Diabetic Retinopathy: A Single-center Retrospective Study[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(2): 143-147. DOI: 10.3969/j.issn.1674-9081.2019.02.011
shu

Correlation of 25-hydroxy Vitamin D and Lipoprotein-associated Phospholipase A2 with Diabetic Retinopathy: A Single-center Retrospective Study

  • 1.

    The Second Department of Endocrinology, Cangzhou Central Hospital, Cangzhou, Hebei 061000, China

  • 2.

    Party Committee Office, Cangzhou Central Hospital, Cangzhou, Hebei 061000, China

  • 3.

    The First Department of Ophthalmology, Cangzhou Central Hospital, Cangzhou, Hebei 061000, China

More Information
  • Corresponding author:

    WANG Lin-xia Tel：0317-2075935，E-mail：wanglinxia82@163.com

  • Received Date: November 07, 2017
  • Issue Publish Date: September 17, 2020
    Graphical Abstract
    • Abstract
  •   Objective  To investigate the correlation of 25-hydroxy vitamin D [25-(OH)D] and lipopro- tein-associated phospholipase A2(LP-PLA2) with diabetic retinopathy(DR).
      Methods  From May 2014 to January 2017, data of patients with type 2 diabetes mellitus from the Department of Endocrinology of Cangzhou Central Hospital were retrospectively analyzed and selected for the study. Patients were divided into three groups according to the Results of fundus photography:type 2 diabetes mellitus without retinopathy (NDR group), background type 2 diabetic retinopathy(BDR group), and proliferative stage 2 diabetic retinopathy (PDR group), and healthy subjects who took a medical examination were selected as the control group. Relative biochemical indexes were compared among the four groups.Pearson correlation analysis and multiple Logistic regression were carried out to analyze the correlated and independent risk factors.
      Results  Three hundred and forty type 2 diabetic patients (NDR group:125 cases, BDR group: 118 cases, PDR group: 97 cases) and 100 healthy controls were selected for this study. There was no significant difference in sex, age, body mass index, systolic blood pressure, diastolic blood pressure, total cholesterol, triglyceride, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and fasting blood glucose among the four groups (all P > 0.05). The course of the NDR group was shorter than that of the BDR group, and the later was shorter than that of the PDR group (P < 0.05). Compared with the control group, glycated hemoglobin A1c(HbA1c), glycated albumin (GA), serum cystatin C (Cys-C), and LP-PLA2 were significantly higher, and 25(OH)D was significantly lower in NDR group, BDR group, and PDR group(all P < 0.05). Among the BDR group, PDR group, and NDR group, HbA1c, GA, Cys-C, LP-PLA2, and 25(OH)D also had significant differences (all P < 0.05). After Pearson correlation analysis, the course of the disease, HbA1c, GA, Cys-C, and LP-PLA2 were positively correlated with DR (all P=0.000), and 25(OH)D had a negative correlation with DR(P=0.000). After Logistic regression analysis, the course of the disease, HbA1c, Cys-C, and LP-PLA2 were independent risk factors of DR, and 25(OH)D was the protective factor of DR(all P < 0.05).
      Conclusions  25(OH)D and LP-PLA2 levels are closely related to the occurrence and development of DR. 25(OH)D is the protective factor, and LP-PLA2 is a risk factor.
    • FullText(HTML)
    • References (19)
  • [1]
    韩睿, 朱钊, 刘华, 等.昆明地区家族性2型糖尿病伴糖尿病视网膜病变患者中血清25羟维生素D3的检测意义[J].重庆医科大学学报, 2015, 12:1006-1011. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=cqykdxxb201507024
    [2]
    夏维波.维生素D及其类似物临床应用共识[J].协和医学杂志, 2018, 9:127-143. DOI: 10.3969/j.issn.1674-9081.2018.02.007
    [3]
    刘燕萍, 金洽尔, 包媛媛, 等.妊娠糖尿病孕妇孕中晚期维生素D营养状态及成因分析[J].协和医学杂志, 2017, 8:20-24. DOI: 10.3969/j.issn.1674-9081.2017.01.005
    [4]
    Lucato P, Solmi M, Maggi S, et al.Low vitamin D levels increase the risk of type 2 diabetes in older adults: a systematic review and meta-analysis[J].Maturitas, 2017, 100:8-15. DOI: 10.1016/j.maturitas.2017.02.016
    [5]
    Shen L, Zhuang QS, Ji HF.Assessment of vitaminD levels in type1 and type2 diabetes patients: results from meta-analysis[J].Mol Nutr Food Res, 2016, 60:1059-1067. DOI: 10.1002/mnfr.201500937
    [6]
    胡小磊, 宋宜宁, 张士荣, 等. 2型糖尿病视网膜病变与血清25羟维生素D水平的关系研究[J].蚌埠医学院学报, 2016, 41:574-576. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=bbyxyxb201605005
    [7]
    American Diabetes Association. Standards of Medical Care in Diabetes-2013[J].Diabetes Care, 2013, 36:S11-S66.
    [8]
    葛坚.眼科学[M].北京: 人民卫生出版社出版, 2005: 304-305.
    [9]
    李锦, 李晓华, 王勤.25-羟基维生素D3水平与2型糖尿病视网膜病变的关系研究[J].河北医药, 2014, 36: 1206-1207. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=hbyy201408040
    [10]
    张冬艳, 马鸿雁, 苏军燕, 等.血清结缔组织生长因子、25-羟维生素D、脂联素检测在2型糖尿病视网膜病变诊断及病情评价中的价值[J].中国实验诊断学, 2017, 21:505-509 http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgsyzdx201703044
    [11]
    韩改玲, 鲁娜, 王翠娟, 等. 25(OH)D与2型糖尿病视网膜病变程度的相关性[J].山东医药, 2013, 53:34-35. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=shandyy201309012
    [12]
    钱超, 余建华, 谷费菲, 等.糖尿病足患者脂蛋白相关磷脂酶A2 D-二聚体及纤维蛋白原水平分析[J].国际检验医学杂志, 2015, 36:3303-3304. DOI: 10.3969/j.issn.1673-4130.2015.22.035
    [13]
    林秀红, 徐明彤, 麦梨芳, 等.新诊断2型糖尿病患者血浆脂蛋白相关性磷脂酶A2及分泌型磷脂酶A2水平与动脉粥样硬化的相关研究[J].中华内分泌代谢杂志, 2016, 32:470-474. DOI: 10.3760/cma.j.issn.1000-6699.2016.06.007
    [14]
    姚建华.糖尿病冠状动脉粥样硬化性心脏病患者测定血清脂蛋白相关磷脂酶A2和血脂水平的临床价值[J].中国血液流变学杂志, 2015, 25:89-92. DOI: 10.3969/j.issn.1009-881X.2015.01.030
    [15]
    唐瑶.青年人血清脂蛋白相关磷脂酶A2水平与胰岛素抵抗的关系及临床意义[D].重庆医科大学, 2015.
    [16]
    林秀红, 徐明彤, 麦梨芳, 等.短期胰岛素强化治疗对新诊断2型糖尿病患者血浆脂蛋白相关性磷脂酶A2及分泌型磷脂酶A2水平的影响[J].中华内科杂志, 2017, 56:127-129. DOI: 10.3760/cma.j.issn.0578-1426.2017.02.009
    [17]
    孙耀峰, 籍继颖, 刘晓丹, 等.脂蛋白相关磷脂酶A2水平检测对2型糖尿病并发动脉粥样硬化患者的临床意义[J].国际检验医学杂志, 2015, 36:3243-3245. DOI: 10.3969/j.issn.1673-4130.2015.22.009
    [18]
    邓爱红, 黄泽棋, 董少文, 等.老年2型糖尿病患者糖化血红蛋白控制水平与脂蛋白相关磷脂酶A2浓度和肾功能指标变化的临床分析[J].医学检验与临床, 2014, 25:53-55. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=qlyxjy201406021
    [19]
    吴萍, 殷峻, 刘芳, 等.低25羟维生素D水平与糖尿病视网膜病变的相关性分析[J].中国糖尿病杂志, 2014, 22:220-223. DOI: 10.3969/j.issn.1006-6187.2014.03.008
    • Related Articles

  • Related Articles

    [1]GONG Chao, YU Na, CHEN Haoran. Clinical Phenotype Identification and Validation of Patients with Sepsis in the Intensive Care Unit[J]. Medical Journal of Peking Union Medical College Hospital. DOI: 10.12290/xhyxzz.2024-0353
    [2]SONG Tianjiao, WANG Xiaoting, CHAO Yangong. Particle Multimodality Monitoring and Hemodynamics[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(6): 942-947. DOI: 10.12290/xhyxzz.2022-0626
    [3]ZHAO Hua, LIU Dawei. How to Implement Personalized Therapy According to Clinical Guidelines: From International Guidelines for Management of Sepsis and Septic Shock[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(2): 174-179. DOI: 10.12290/xhyxzz.2021-0811
    [4]YU Jiren, WANG E, WANG Difen, CANG Jing, FENG Yi, ZHANG Xijing, YANG Yi, YANG Yunmei, WU Shuijing, WANG Weijian, DU Bin, SHANG You, LIN Ru, CHENG Baoli, XIE Guohao, FANG Xiangming. Expert Consensus on Perioperative Management of Elderly Septic Patients (2021)[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(4): 481-489. DOI: 10.12290/xhyxzz.2021-0312
    [5]Li LI, Jing YAN. Dramatic Changes in Hemodynamics from the Changes of Surviving Sepsis Campaign Guidelines[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(5): 446-449. DOI: 10.3969/j.issn.1674-9081.2019.05.004
    [6]Yan KANG. Treatments of Sepsis and Septic Shock: Advancements in Controversy[J]. Medical Journal of Peking Union Medical College Hospital, 2018, 9(5): 421-425. DOI: 10.3969/j.issn.1674-9081.2018.05.009
    [7]Na CUI, Da-wei LIU. Attach Importance to the Diagnosis and Treatment of Infection:Stand for Infectious Disease Society of America[J]. Medical Journal of Peking Union Medical College Hospital, 2018, 9(5): 417-420. DOI: 10.3969/j.issn.1674-9081.2018.05.008
    [8]Yun LONG, Da-wei LIU. Sepsis Is Not Infection: Stard for Surviving Sepsis Campaign[J]. Medical Journal of Peking Union Medical College Hospital, 2018, 9(5): 411-416. DOI: 10.3969/j.issn.1674-9081.2018.05.007
    [9]Kui JIN, Jun XU, Xue-zhong YU. Sepsis and Septic Shock in Emergency Department: Management and Process Optimization[J]. Medical Journal of Peking Union Medical College Hospital, 2018, 9(5): 389-392. DOI: 10.3969/j.issn.1674-9081.2018.05.002
    [10]Han-bin WANG, Ya-qi SUN, Xiang-ming FANG. Influence and Countermeasures of Medical Resource Allocation on the Occurrence and Development of Sepsis[J]. Medical Journal of Peking Union Medical College Hospital, 2017, 8(6): 326-331. DOI: 10.3969/j.issn.1674-9081.2017.06.002

  • Cited by

    Periodical cited type(6)

    1. 厉弘博，钱益，李珂璇，王晨，孙振，孙曦羽，徐徕，张冠南，吴斌，林国乐，陆君阳，胡克，肖毅. 新辅助治疗反应不佳的直肠癌患者预后影响因素及相关生存分析. 中华胃肠外科杂志. 2025(01): 48-57 .
    2. 韦建雍，于祥田，沈赟，胡承. 综合性公立医院专病数据库的建设思路及临床研究应用. 中华糖尿病杂志. 2024(01): 127-132 .
    3. 李哲明，朱珠，黄坚，施珊珊，俞刚. 面向科研专病库的可视化前置数据采集系统建设探索与实践. 中国卫生信息管理杂志. 2024(01): 69-74 .
    4. 冯雨萱，郑锐，于广军. 我国临床专病数据库建设情况概述. 上海医药. 2024(09): 10-13+18 .
    5. 孙振，周炜洵，李珂璇，吴斌，林国乐，邱辉忠，牛备战，孙曦羽，陆君阳，徐徕，肖毅. 肿瘤位置和错配修复状态对非转移性结肠癌患者临床病理特征及生存的影响. 中华胃肠外科杂志. 2024(06): 591-599 .
    6. 王浩，孟祥峰，郝烨，李佳戈，李静莉. 行业标准《人工智能医疗器械 质量要求和评价 第2部分：数据集通用要求》解析. 协和医学杂志. 2023(06): 1180-1184 . 本站查看

    Other cited types(0)

Catalog

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (588) PDF downloads (405) Cited by(6)
    Related
    Links: National Health Commission of the People's Republic of China Chinese Academy of Medical Sciences(CAMS) AMLC Check CNKI Database CNKI Term Online Chinese General Practice
    Address：Room 302,Third Floor,Building 7, No. 1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing 100730, China
    Tel：010-69154261/4262
    E - mail：medj@pumch.cn mjpumch@126.com
    Copyright of website：Editorial Office of Medical Journal of Peking Union Medical College Hospital

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close